Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00254995
Status:
COMPLETED
Last Update Posted:
2016-04-19
First Post:
2005-11-15
Brief Title:
Descriptive Post-marketing Surveillance Safety Study of Menactra Vaccine
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Study Overview
Official Title:
Post-licensure Safety Surveillance Study of Routine Use of Meningococcal Groups A C Y and W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine Menactra
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events AEs not detected during pre-licensure studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None